Skip to main content

Laser-Assisted Labiaplasty

Laser-assisted labiaplasty uses a laser, most commonly a CO₂ laser at 10,600 nm, as the cutting or excision instrument in place of a scalpel or scissors during a standard labiaplasty. Some reviews list laser labiaplasty as its own technique,[1][2] but the laser is a cutting tool that can be used with any resection pattern (trim, wedge, de-epithelialization, hood-extending hockey stick). Across mostly nonrandomized series, a 2024 meta-analysis reported less bleeding, swelling and hematoma with laser than scalpel, but included only five laser studies and found no significant difference in overall complications.[4] A 2022 meta-analysis found the highest pooled dehiscence among techniques for laser-assisted labiaplasty (5%, 95% CI 2–8%);[3] the lateral zone of thermal coagulation at the wound edge is a proposed explanation, and the 2024 meta-analysis pooled wedge resection dehiscence higher (8%, 95% CI 5–13%).[4] For positioning versus other female cosmetic options see Cosmetic Genital Surgery — Female.

Society positioning and FDA distinction. The FDA 2018 Safety Communication warned against the use of energy-based devices (lasers, RF) for vaginal "rejuvenation" or cosmetic vaginal procedures, citing serious adverse events including vaginal burns, scarring, pain during intercourse and recurring or chronic pain. The FDA had not cleared or approved any energy-based device for these indications.[19] ACOG 2020 advises counseling on limited effectiveness evidence and surgical risks, assessment for body dysmorphic disorder when indicated, and referral for suspected psychological concerns before elective cosmetic surgery; it distinguishes procedures performed for clinical indications.[5] The FIGO 2025 statement defines cosmetic genital surgery as aesthetic alteration in women without structural or functional abnormalities and calls it ethically inappropriate for obstetrician-gynecologists to recommend, perform or refer patients for those procedures; it also finds insufficient evidence for cosmetic laser devices.[20] Qureshi 2018 reviews nonsurgical vulvovaginal laser applications.[6] The later FDA communication concerns vaginal rejuvenation and cosmetic vaginal procedures; it does not evaluate excisional vulvar labiaplasty or establish clearance for a particular surgical cutting device.[19]

Distinguishing surgical laser labiaplasty from non-surgical "rejuvenation"​

UseWhat the laser doesTissue removalFDA clearance
Surgical laser labiaplastyReplaces scalpel as cutting tool during excisional labiaplastyYes — full-thickness or epithelial excisionCheck the specific device’s cleared surgical intended use; the 2018 FDA communication does not establish clearance for this operation[19]
Non-surgical vulvovaginal "rejuvenation"Fractional CO₂ or Er:YAG protocols aim for tissue remodeling without labial excision; fractional CO₂ can cause superficial microablation[23]No labial excision; fractional CO₂ may remove microscopic tissueNot FDA-cleared for cosmetic / "rejuvenation" indications[5][6]

The two uses are easily conflated in counseling and marketing.

Laser types​

LaserWavelengthRole
CO₂10,600 nmCommonly reported for surgical labiaplasty. High water absorption permits precise tissue vaporization with simultaneous coagulation; power and pulse mode depend on the device and operative plan.[7][8]
Diode810–980 nmDeeper thermal increase than CO₂ or Er:YAG in an ex vivo bovine tongue model (5 W diode). Less commonly used for labiaplasty.[9]
Er:YAG2,940 nmProduced the smallest thermal increase in the cited ex vivo tissue model. Er:YAG has also been studied for nonsurgical vaginal indications, which are distinct from excisional labiaplasty.[9][10]
Radiofrequency (not a laser)Not applicableSome series group RF cutting (e.g., Ellman Surgitron) with energy-assisted labiaplasty. Curvilinear labiaplasty using RF has been described by its authors as precise and safe.[11]

Surgical technique (laser excision; Pardo 2006 used Nd:YAG)​

The laser substitutes for the scalpel during excision; the rest of the procedure follows whatever resection pattern is planned (trim, wedge, de-epithelialization, hockey stick).[12]

StepDetail
1. Position and anesthesiaLithotomy. Local with epinephrine, with or without sedation, or general.
2. MarkingThe chosen resection pattern is marked with a surgical pen — linear, V, modified, or hood-extending.
3. Laser excisionCut along the marked line using the selected surgical laser and its device-specific tissue-excision settings.[12] Assess the wound bed for bleeding; laser coagulation may control small vessels, while larger vessels can require cautery or ligation.[8]
4. HemostasisHemostasis depends on wavelength and settings; the cited Er:YAG series used compression clamps. Larger vessels can still require selective bipolar electrocautery or suture ligation.[21][8]
5. ClosureApproximation with fine absorbable suture (4-0 or 5-0 polyglactin or chromic gut), as in conventional labiaplasty.[12]
6. Specimen handlingIf the excised tissue is sent for histopathology, note that laser excision creates a thermal-artifact zone at the margins that can complicate margin interpretation.[16]

Safety requirements. Laser use calls for eye protection for all OR personnel, smoke and plume evacuation (laser plume is a recognized occupational hazard), and a designated laser safety officer per institutional laser-safety policy. Allow flammable skin preparation to dry before draping, prevent oxygen and nitrous oxide from accumulating beneath drapes, and moisten gauze near the beam to reduce fire risk.[22]

Outcomes by cutting tool in the Géczi 2024 pooled studies​

The Géczi 2024 systematic review and meta-analysis (53 studies with quantitative data) compared cutting tools across labiaplasty techniques. Scalpel had a significantly higher incidence than laser of bleeding, swelling and hematoma:[4]

ParameterLaserScalpelSignificance
Reported bleedingLowerHigherBetween-tool subgroup difference (p = 0.004)[4]
Postoperative swellingLowerHigherSignificant (p < 0.05)
HematomaLowerHigherSignificant (p < 0.05)

Other properties, drawn from tissue-level and non-labiaplasty studies rather than the Géczi meta-analysis:

ParameterLaserScalpel
Hemostasis during surgerySimultaneous coagulation[8]Requires separate cautery
Early healingNon-genital incision studies report slower early re-epithelialization after CO₂ laser[15]Comparator in the cited non-genital studies
Lateral thermal damagePresent; extent varies with tissue and laser settings[15][16][24]Minimal

Pardo 2006, a single-center Nd:YAG laser series, reported 50/55 very satisfied and 5/55 satisfied at 60 days among patients aged 10–55 years.[12] ACOG advises considering labiaplasty before age 18 only for significant congenital malformation or persistent symptoms directly attributable to labial anatomy.[5] Four of 55 had minimal early suture dehiscence, all healing without intervention.[12][21]

The dehiscence trade-off​

The Escandón 2022 systematic review and meta-analysis of labia minoraplasty reported the highest pooled dehiscence for laser-assisted labiaplasty at 5% (95% CI 2–8%), followed by wedge resection at 3% (1–5%).[3] The Géczi 2024 meta-analysis pooled wedge resection dehiscence at 8% (5–13%).[4]

Proposed mechanism. CO₂ laser excision produces a lateral zone of thermal injury whose extent depends on tissue and laser settings.[24] In non-genital models, compared with cold-steel incisions, this zone shows:[14][15][16]

  • Delayed early-phase re-epithelialization
  • Reduced early collagen deposition
  • Lower early tensile strength

These differences are described as equalizing over time. They may raise dehiscence risk in the first 1–2 weeks.

Advantages​

  • Bleeding. Laser series reported fewer bleeding events than scalpel series; CO₂ laser cutting can also coagulate small vessels.[4][8]
  • Swelling. Less postoperative swelling and hematoma in the Géczi 2024 meta-analysis.[4]
  • Precision. Tissue is removed with little mechanical trauma, which helps in anatomically constrained access.[8]
  • Setting. Office-based CO₂ laser surgery under local anesthesia has been described for benign lower genital tract conditions.[13]
  • Combination. Pardo 2006 reported laser labiaplasty with other gynecologic procedures in a 55-patient series; it did not compare complication rates by concomitant procedure.[12]

Disadvantages​

  • Dehiscence. Highest pooled dehiscence among techniques in the Escandón 2022 meta-analysis (5%; 2–8%).[3]
  • Thermal damage. CO₂ laser creates a setting-dependent lateral zone of injury; delayed early healing is reported in non-genital wounds, and thermal artifact can complicate margin histology.[15][16][24]
  • Equipment cost. CO₂ systems require capital investment and maintenance.[8]
  • Safety overhead. Eye protection, plume evacuation and a laser safety officer are needed.
  • Learning curve. Laser physics, tissue interaction and safety training are needed.
  • Histologic artifact. Thermal artifact appears at specimen margins.[16]
  • Regulatory confusion. Surgical laser labiaplasty is easily conflated with the FDA-warned non-surgical "vaginal rejuvenation" use of energy-based devices.[19]

Tool comparison — laser vs scalpel vs RF / electrocautery​

FeatureCO₂ laserScalpelElectrocautery / RF
HemostasisSimultaneous with cuttingRequires separate cauteryGood
Lateral thermal damageModerateMinimalModerate–high
Reported bleedingLower in pooled laser series, not CO₂-specific[4]Higher in scalpel series[4]Comparative RF rate not established
Dehiscence (pooled)No CO₂-specific rate; laser-assisted labiaplasty as a technique: 5% (95% CI 2–8%) in Escandón 2022[3]Wedge resection as a technique: 8% (95% CI 5–13%) in Géczi 2024, with no significant laser–scalpel difference in dehiscence[4]Not pooled
Early wound healingEarly delay reported in non-genital CO₂ wounds[15]Comparator in non-genital studies[14]Labiaplasty-specific comparison unavailable
CostHighLowModerate
Safety overheadExtensive (eye protection, plume)MinimalModerate

Long-term outcomes context​

In nine studies reporting complications at ≥1 year after labiaplasty (748 patients), McGrattan 2025 found postoperative asymmetry or redundancy in 45/748 (6.0%), revisional surgery in 42/748 (5.6%), and scarring, jagged appearance or over-resection in 14/748 (1.9%). Tool-level data distinguishing laser from scalpel at long-term follow-up are limited.[17]

Toplu 2021 described labia minora reduction alongside optional fat injection and fractional CO₂ laser in a 37-patient combined surgical and nonsurgical genital beautification series. Counsel separately about the fractional laser component in light of the FDA warning on vaginal rejuvenation devices.[18][19]

Postoperative management​

  • Activity restriction. Avoid intercourse, tampon use, and strenuous exercise for 4–6 weeks, with particular attention to the first 1–2 weeks, when dehiscence is most likely.
  • Wound care. Ice / cold compresses 48–72 h; sitz baths from 24–48 h; topical antibiotic ointment; loose-fitting clothing.
  • Smoking cessation. Advised preoperatively when feasible.
  • Follow-up. 1 week (active dehiscence surveillance), 2 weeks, 6 weeks (clearance), 3–6 months (intermediate outcome).
  • PRO assessment. FSFI and FGSIS at baseline and ≥ 6 months postoperatively.

See Also​

References​

1. Oranges CM, Sisti A, Sisti G. Labia minora reduction techniques: a comprehensive literature review. Aesthet Surg J. 2015;35(4):419–431. doi:10.1093/asj/sjv023

2. Motakef S, Rodriguez-Feliz J, Chung MT, et al. Vaginal labiaplasty: current practices and a simplified classification system for labial protrusion. Plast Reconstr Surg. 2015;135(3):774–788. doi:10.1097/PRS.0000000000001000

3. Escandón JM, Duarte-Bateman D, Bustos VP, et al. Maximizing safety and optimizing outcomes of labiaplasty: a systematic review and meta-analysis. Plast Reconstr Surg. 2022;150(4):776e–788e. doi:10.1097/PRS.0000000000009552

4. Géczi AM, Varga T, Vajna R, et al. Comprehensive assessment of labiaplasty techniques and tools, satisfaction rates, and risk factors: a systematic review and meta-analysis. Aesthet Surg J. 2024;44(11):NP798–NP808. doi:10.1093/asj/sjae143

5. Committee on Gynecologic Practice, American College of Obstetricians and Gynecologists. Elective female genital cosmetic surgery: ACOG Committee Opinion No. 795. Obstet Gynecol. 2020;135(1):e36–e42. doi:10.1097/AOG.0000000000003616

6. Qureshi AA, Tenenbaum MM, Myckatyn TM. Nonsurgical vulvovaginal rejuvenation with radiofrequency and laser devices: a literature review and comprehensive update for aesthetic surgeons. Aesthet Surg J. 2018;38(3):302–311. doi:10.1093/asj/sjx138

7. Wright VC. Laser surgery: using the carbon dioxide laser. Can Med Assoc J. 1982;126(9):1035–1039. PMID 7074503

8. Campolmi P, Bonan P, Cannarozzo G, et al. Highlights of thirty-year experience of CO2 laser use at the Florence (Italy) Department of Dermatology. ScientificWorldJournal. 2012;2012:546528. doi:10.1100/2012/546528

9. Merigo E, Clini F, Fornaini C, et al. Laser-assisted surgery with different wavelengths: a preliminary ex vivo study on thermal increase and histological evaluation. Lasers Med Sci. 2013;28(2):497–504. doi:10.1007/s10103-012-1081-8

10. Ippolito GM, Crescenze IM, Sitto H, et al. Vaginal lasers for treating stress urinary incontinence in women. Cochrane Database Syst Rev. 2025;7:CD013643. doi:10.1002/14651858.CD013643.pub2

11. Ghozland D, Alinsod R. Curvilinear labiaplasty and clitoral hood reduction surgery. Clin Plast Surg. 2022;49(4):455–471. doi:10.1016/j.cps.2022.06.007

12. Pardo J, Solà V, Ricci P, Guilloff E. Laser labioplasty of labia minora. Int J Gynaecol Obstet. 2006;93(1):38–43. doi:10.1016/j.ijgo.2006.01.002

13. Frega A, Verrone A, Schimberni M, et al. Feasibility of office CO2 laser surgery in patients affected by benign pathologies and congenital malformations of female lower genital tract. Eur Rev Med Pharmacol Sci. 2015;19(14):2528–2536. PMID 26221878

14. Liboon J, Funkhouser W, Terris DJ. A comparison of mucosal incisions made by scalpel, CO2 laser, electrocautery, and constant-voltage electrocautery. Otolaryngol Head Neck Surg. 1997;116(3):379–385. doi:10.1016/S0194-5998(97)70277-8

15. Hendrick DA, Meyers A. Wound healing after laser surgery. Otolaryngol Clin North Am. 1995;28(5):969–986. doi:10.1016/s0030-6665(20)30470-9

16. Filmar S, Jetha N, McComb P, Gomel V. A comparative histologic study on the healing process after tissue transection. II. Carbon dioxide laser and surgical microscissors. Am J Obstet Gynecol. 1989;160(5 Pt 1):1068–1072. doi:10.1016/0002-9378(89)90162-2

17. McGrattan M, Majeed A, Hanna SA. Long-term functional and aesthetic outcomes of labiaplasty: a review of the literature. Aesthet Surg J. 2025;45(2):180–185. doi:10.1093/asj/sjae211

18. Toplu G, Altinel D. Genital beautification and rejuvenation with combined use of surgical and non-surgical methods. Aesthet Plast Surg. 2021;45(2):758–768. doi:10.1007/s00266-020-01980-z

19. US Food and Drug Administration. FDA warns against use of energy-based devices to perform vaginal "rejuvenation" or vaginal cosmetic procedures: FDA safety communication. July 30, 2018. fda.gov

20. Capito L, Antsaklis A, Gupte S; FIGO Committee on Ethical Aspects of Human Reproduction and Women's Health. FIGO statement: cosmetic genital surgery. Int J Gynaecol Obstet. 2025;170(1):11–14. doi:10.1002/ijgo.70203

21. Bizjak-Ogrinc U, Senčar S. "Sutureless laser labiaplasty of labia minora." Sex Med. 2021;9(5):100406. doi:10.1016/j.esxm.2021.100406

22. Apfelbaum JL, Caplan RA, Barker SJ, et al. "Practice advisory for the prevention and management of operating room fires: an updated report by the American Society of Anesthesiologists Task Force on Operating Room Fires." Anesthesiology. 2013;118(2):271–290. doi:10.1097/ALN.0b013e31827773d2

23. Salvatore S, Leone Roberti Maggiore U, Athanasiou S, et al. "Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study." Menopause. 2015;22(8):845–849. doi:10.1097/GME.0000000000000401

24. González-Isaza P, Lotti T, França K, et al. "Carbon Dioxide with a New Pulse Profile and Shape: A Perfect Tool to Perform Labiaplasty for Functional and Cosmetic Purpose." Open Access Maced J Med Sci. 2018;6(1):25–27. doi:10.3889/oamjms.2018.043